Hong Seng to acquire 51% in RZAC


PETALING JAYA: Hong Seng Consolidated Bhd’s wholly-owned subsidiary, HS Bio Sdn Bhd, has signed a heads of agreement following a proposed acquisition of 51% shareholdings in RZAC Immunesafe Sdn Bhd for RM40.3mil.

In a filing with Bursa Malaysia yesterday, the company said the agreement was signed with Datuk Seri Shahril Mokhtar, Datuk Wan Khalik Wan Muhammad and RZAC Business Sdn Bhd. – Bernama

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
   

Next In Business News

Banking stocks lift FBM KLCI higher
Oil prices ease, Russia, Iran tensions check losses
Gold drops nearly 2% on profit-booking, Trump's Treasury secretary pick
Bonds bounce, dollar dips on Bessent pick
Mr DIY Indonesian business plans IPO to raise up to US$297mil
China's NEV market in a league of its own
Singapore Oct core inflation at 2.1% y/y, lowest in almost 3 years
TMK Chemicals aims to raise RM385mil from Main Market IPO
Malaysia's September LI up 1.8%, shows continued economic growth - DoSM
CBH Engineering inks underwriting deal with Mercury Securities

Others Also Read